Analysis Tools
immune system
|
• DSS-treated mice exhibit reduced weight loss, colonic inflammation and colon length shortening with protection from inflammatory destruction, tissue remodeling and leukocyte infiltration compared with wild-type mice
|
|
• in bronchoalveolar lavage fluid of mice treated with ovalbumin and alum to induce asthma
|
|
• upon ovalbumin restimulation in mice treated with ovalbumin and alum to induce asthma
|
|
• fewer infiltrating inflammatory cells in the bronchoalveolar lavage fluid after repeated intranasal allergen challenge with the Aspergillus oryzae protease and OVA protein
|
|
• reduced CCL2 in the colon tissue of DDS-treated mice compared with wild-type mice
|
|
• decreased IL22 in colon tissue of C. rodentium-infected mice
|
|
• in the colon tissue of DDS-treated mice
|
|
• in draining lymph nodes and bronchoalveolar lavage 24 hrs after last challenge, where mice were sensitized with OVA in alum at day 0 and 14, followed by intranasal challenge with OVA at day 14, 25, 26 and 27
(J:158594)
• in bronchoalveolar lavage fluid of mice treated with ovalbumin and alum to induce asthma
(J:229778)
|
|
• in the bronchoalveolar lavage fluid after repeated allergen challenge
(J:158594)
• in draining lymph nodes and bronchoalveolar lavage 24 hrs after last challenge, where mice were sensitized with OVA in alum at day 0 and 14, followed by intranasal challenge with OVA at day 14, 25, 26 and 27
(J:158594)
• in bronchoalveolar lavage fluid of mice treated with ovalbumin and alum to induce asthma
(J:229778)
|
|
• in the bronchoalveolar lavage fluid after repeated allergen challenge
(J:158594)
• in draining lymph nodes and bronchoalveolar lavage 24 hrs after last challenge, where mice were sensitized with OVA in alum at day 0 and 14, followed by intranasal challenge with OVA at day 14, 25, 26 and 27
(J:158594)
• in bronchoalveolar lavage fluid of mice treated with ovalbumin and alum to induce asthma
(J:229778)
|
|
• in draining lymph nodes and bronchoalveolar lavage 24 hrs after last challenge , where mice were sensitized with OVA in alum at day 0 and 14, followed by intranasal challenge with OVA at day 14, 25, 26 and 27
|
|
• in the colon tissue of DDS-treated mice
|
|
• fewer infiltrating inflammatory cells in the bronchoalveolar lavage fluid after repeated intranasal allergen challenge with the Aspergillus oryzae protease and OVA protein
|
|
• Citrobacter rodentium-infected mice exhibit reduced weight loss and fecal bacteria compared with wild-type mice
|
respiratory system
|
• fewer infiltrating inflammatory cells in the bronchoalveolar lavage fluid after repeated intranasal allergen challenge with the Aspergillus oryzae protease and OVA protein
|
growth/size/body
|
• in DSS-treated mice
• Citrobacter rodentium-infected mice exhibit reduced weight loss compared with wild-type mice
|
digestive/alimentary system
|
• reduced DSS-induced colon shortening compared with wild-type mice
|
|
• DSS-treated mice exhibit reduced weight loss, colonic inflammation and colon length shortening with protection from inflammatory destruction, tissue remodeling and leukocyte infiltration compared with wild-type mice
|
hematopoietic system
|
• in bronchoalveolar lavage fluid of mice treated with ovalbumin and alum to induce asthma
|
|
• upon ovalbumin restimulation in mice treated with ovalbumin and alum to induce asthma
|
